Research Summary
Research Summary
01/02/2025
Miranda Manier, BA
A new retrospective study examines treatment trends among men with limited life expectancy diagnosed with prostate cancer in the Veterans Affairs health system from 2000 to 2019. Researchers explored...
01/02/2025
FDA Alert
FDA Alert
01/01/2025
Anthony Calabro, MA
The FDA has approved tirzepatide, the first-ever drug option to treat moderate to severe obstructive sleep apnea in adults with obesity.
01/01/2025
Research Summary
Research Summary
12/17/2024
Miranda Manier, BA
Environmental detection of SARS-CoV-2 in hospital staff areas may offer early insights into impending COVID-19 outbreaks, according to recent research out of Canada.
12/17/2024
Public Health
Public Health
11/18/2024
Miranda Manier, BA
The CDC has updated its guidelines for COVID-19 and pneumococcal vaccines, aiming to boost protection for high-risk populations against severe disease year-round.
11/18/2024
COVID-19 ROUNDUP
COVID-19 ROUNDUP
10/28/2024

Anthony Calabro, MA

Anthony Calabro, MA
In this COVID-19 roundup, researchers report on the risk of health issues and death among patients hospitalized with COVID-19 at 3 year-follow-up, the widespread overuse of antibiotics among patients with...
10/28/2024
Research summary
Research summary
10/28/2024
Anthony Calabro, MA
In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.
10/28/2024
Respiratory Diseases Roundup
Respiratory Diseases Roundup
10/24/2024
Anthony Calabro, MA
In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...
10/24/2024
Research Summary
Research Summary
10/08/2024
Anthony Calabro, MA
Breast cancer deaths have fallen by 44% since 1989, according to a new report by the American Cancer Society.
10/08/2024
Conference Coverage
Conference Coverage
10/07/2024
Anthony Calabro, MA
Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.
10/07/2024
FDA Alert
FDA Alert
09/30/2024
Miranda Manier, BA
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
09/30/2024